Pulmonx Corporation (LUNG) Financials
LUNG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 164.6 million | 54.1 million |
| 2023-12-31 | 179.0 million | 60.6 million |
| 2023-09-30 | 185.0 million | 59.3 million |
| 2023-06-30 | 193.1 million | 59.2 million |
LUNG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | -8.6 million | 5.6 million |
| 2023-09-30 | -9.1 million | 6.0 million |
| 2023-06-30 | -7.9 million | 5.9 million |
LUNG Net Income
No data available :(
LUNG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 116.1 million | - | - |
| 2023-12-31 | 117.3 million | - | 4.2 million |
| 2023-09-30 | 116.5 million | - | 5.0 million |
| 2023-06-30 | 135.2 million | 37.1 million | 5.8 million |
LUNG Shares Outstanding
LUNG Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 4.2 million | - | - |
| 2023-12-31 | 200000 | 3.9 million | 19.5 million | 4.8 million |
| 2023-09-30 | 492000 | 4.2 million | 24.0 million | - |
| 2023-06-30 | 54000 | 5.7 million | 23.5 million | - |
LUNG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 18.9 million | 4.8 million |
| 2023-12-31 | 19.3 million | 5.0 million |
| 2023-09-30 | 17.7 million | 4.6 million |
| 2023-06-30 | 17.2 million | 4.5 million |
LUNG
Price: $9.82
52 week price:
Earnings Per Share: -1.60 USD
P/E Ratio: -8.80
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 23949
Market Capitalization: 381.1 million